Alefacept in Subjects With Chronic Plaque Psoriasis Who Failed to Respond to Anti-TNF Therapy
NCT00953329
·
clinicaltrials.gov ↗
PHASE4
Phase
TERMINATED
Status
1
Enrollment
OTHER
Sponsor class
Stopped
Subjects declined enrollment; sponsor/PI elected to close study.
Conditions
Chronic Plaque Psoriasis
Interventions
DRUG:
alefacept
Sponsor
John Murray
Collaborators
[object Object]